| Biotechnology feed | All feeds
The product will be available in two... Medical News Today: Feb 9 2010 4:13PM Matching: hydrochloride Find similar documents
8 (HSMN NewsFeed) -- Sagent Pharmaceuticals, Inc., a privately held specialty pharmaceutical company, today announced that it has received FDA approval of labetalol hydrochloride (HCl) injection, USP, commonly used to control severe... Healthcare Sales & Marketing Network: Feb 9 2010 1:18PM Matching: hydrochloride Find similar documents
The product will be available in two... BioFind: Feb 9 2010 1:04PM Matching: hydrochloride Find similar documents
The product will be available in... MedIndia: Feb 9 2010 8:33AM Matching: hydrochloride Find similar documents
Cetrizine Hydrochloride... Therapeutics Daily: Feb 8 2010 12:21PM Matching: hydrochloride Find similar documents
8 /PRNewswire/ -- Sagent Pharmaceuticals, Inc., a privately held specialty pharmaceutical company, today... PR Newswire: Feb 8 2010 4:09PM Matching: hydrochloride Find similar documents
8 /PRNewswire/ Sagent Pharmaceuticals, Inc., a privately held specialty pharmaceutical company, today announced that it has received FDA approval of labetalol hydrochloride (HCl) injection, USP, commonly used to control severe... Pharmacy Choice: Feb 8 2010 10:53PM Matching: hydrochloride Find similar documents
8 /PRNewswire/ -- Sagent Pharmaceuticals, Inc., a privately held specialty pharmaceutical company, today announced that it has received FDA approval of labetalol hydrochloride (HCl) injection, USP, commonly used to control severe... Red Orbit: Feb 8 2010 8:15PM Matching: hydrochloride Find similar documents
8 /PRNewswire/ -- Sagent Pharmaceuticals, Inc., a privately held specialty pharmaceutical company, today announced that it has received FDA approval of labetalol hydrochloride (HCl) injection, USP, commonly used to control severe... Pharma Live: Feb 8 2010 7:47PM Matching: hydrochloride Find similar documents
8 /PRNewswire/ -- Sagent Pharmaceuticals, Inc., a privately held specialty pharmaceutical company, today announced that it has received FDA approval of labetalol hydrochloride (HCl) injection, USP, commonly used to control severe... Business Journal of Milwaukee: Feb 8 2010 6:30PM Matching: hydrochloride Find similar documents
8 /PRNewswire/ -- Sagent Pharmaceuticals, Inc., a privately held specialty pharmaceutical company, today announced that it has received FDA approval of labetalol hydrochloride (HCl) injection, USP, commonly used to control severe... Columbus Business First: Feb 8 2010 6:21PM Matching: hydrochloride Find similar documents
8 /PRNewswire/ -- Sagent Pharmaceuticals, Inc., a privately held specialty pharmaceutical company, today announced that it has received FDA approval of labetalol hydrochloride (HCl) injection, USP, commonly used to control severe... Pacific Business News: Feb 8 2010 6:21PM Matching: hydrochloride Find similar documents
8 /PRNewswire/ -- Sagent Pharmaceuticals, Inc., a privately held specialty pharmaceutical company, today announced that it has received FDA approval of labetalol hydrochloride (HCl) injection, USP, commonly used to control severe... Business First of Louisville: Feb 8 2010 6:20PM Matching: hydrochloride Find similar documents
8 /PRNewswire/ -- Sagent Pharmaceuticals, Inc., a privately held specialty pharmaceutical company, today announced that it has received FDA approval of labetalol hydrochloride (HCl) injection, USP, commonly used to control severe... Triad Business Journal: Feb 8 2010 6:18PM Matching: hydrochloride Find similar documents
8 /PRNewswire/ -- Sagent Pharmaceuticals, Inc., a privately held specialty pharmaceutical company, today announced that it has received FDA approval of labetalol hydrochloride (HCl) injection, USP, commonly used to control severe... Business First of Buffalo: Feb 8 2010 5:57PM Matching: hydrochloride Find similar documents
8 /PRNewswire/ -- Sagent Pharmaceuticals, Inc., a privately held specialty pharmaceutical company, today announced that it has received FDA approval of labetalol hydrochloride (HCl) injection, USP, commonly used to control severe... Orlando Business Journal: Feb 8 2010 5:53PM Matching: hydrochloride Find similar documents
8 SCHAUMBURG, Ill., Feb.
8 /PRNewswire/ -- Sagent Pharmaceuticals, Inc., a privately held specialty pharmaceutical company, today announced that it has received FDA approval of labetalol hydrochloride (HCl) injection, USP,... Biz Journals: Feb 8 2010 5:53PM Matching: hydrochloride Find similar documents
'Another product of our joint venture with Strides Arcolab, labetalol is an important addition to our specialty injectable portfolio and enhances our cardiovascular care offering,' said Jeffrey M.
Yordon Labetalol is the third product... Therapeutics Daily: Feb 8 2010 5:48PM Matching: hydrochloride Find similar documents
8 /PRNewswire/ -- Sagent Pharmaceuticals, Inc., a privately held specialty pharmaceutical company, today announced that it has received FDA approval of labetalol hydrochloride (HCl) injection, USP, commonly used to control severe... Sacramento Business Journal: Feb 8 2010 5:43PM Matching: hydrochloride Find similar documents
8 /PRNewswire/ -- Sagent Pharmaceuticals, Inc., a privately held specialty pharmaceutical company, today announced that it has received FDA approval of labetalol hydrochloride (HCl) injection, USP, commonly used to control severe... Pittsburgh Business Times: Feb 8 2010 5:31PM Matching: hydrochloride Find similar documents
The product will be available in... Phoenix Business Journal: Feb 8 2010 5:27PM Matching: hydrochloride Find similar documents
8 /PRNewswire/ -- Sagent Pharmaceuticals, Inc., a privately held specialty pharmaceutical company, today announced that it has received FDA approval of labetalol hydrochloride (HCl) injection, USP, commonly used to control severe... San Antonio Business Journal: Feb 8 2010 5:27PM Matching: hydrochloride Find similar documents
Nothing in this website should be used in place of personal medical advice from your own qualified medical practitioner.
All rights reserved. All other trademarks recognized. Copyright 1997-2009 - BioPortfolio Limited.
